RE:Big Pharma Amgen pays US$2 Billion for Phase 1 companyRepost : - January 05, 2023 - Amgen starts the new year with a bang, licensing-in Synaffix Phase-1 ADC technology for US $2 billion - the largest ADC licensing deal to date.
.........................
Conversely ONCY is a "Phase 3 ready" company with a predicitive diagnostic that is demonstrating to be effective in multiple cancers including pancreatic and breast cancers - which should value ONCY multiple times greater than a Phase 1 company that is still incolved in the safety testing of its product.